Review article: Becoming and being coeliac-special considerations for childhood, adolescence and beyond
- PMID: 35815825
- PMCID: PMC9441244
- DOI: 10.1111/apt.16851
Review article: Becoming and being coeliac-special considerations for childhood, adolescence and beyond
Abstract
Classically considered a disease of early childhood characterised by malabsorption and failure to thrive, coeliac disease is now recognised to arise in genetically susceptible individuals at any age. Although permissive HLA genotypes are the strongest predictor of coeliac disease, they are not sufficient. Several prospective cohort studies enrolling genetically at-risk infants have investigated the role of potential triggers of coeliac disease autoimmunity, such as timing of gluten introduction, viral infections and dietary patterns. Much less is known about triggers of coeliac disease in adulthood. Better understanding of factors leading to coeliac disease may be helpful in the management of those with potential coeliac disease (elevated serum celiac antibodies without villous atrophy in the small intestine), many of whom initiate a gluten-free diet without demonstration of villous atrophy. There are a range of clinical presentations of celiac disease in childhood and patterns of coeliac serology, including fluctuation and spontaneous reversion on a gluten-containing diet, vary. There is a current debate over best strategies to manage adults and children with potential coeliac disease to avoid over-treatment and under-treatment. Childhood and adolescence carry unique issues pertaining to the diagnosis and management of coeliac disease, and include nutrition and growth, rescreening, repeat biopsy, dietary adherence concerns and transition to adult care. In conclusion, while coeliac disease has similar pathogenesis and general clinical manifestations in paediatric and adult populations, diagnostic and management approaches need to adapt to the developmental stages.
Keywords: adolescent; coeliac disease; potential coeliac disease; risk factors.
© 2022 John Wiley & Sons Ltd.
Figures
Similar articles
-
Coeliac disease.Lancet. 2022 Jun 25;399(10344):2413-2426. doi: 10.1016/S0140-6736(22)00794-2. Epub 2022 Jun 9. Lancet. 2022. PMID: 35691302 Review.
-
Optimising delivery of care in coeliac disease - comparison of the benefits of repeat biopsy and serological follow-up.Aliment Pharmacol Ther. 2013 Nov;38(10):1278-91. doi: 10.1111/apt.12510. Epub 2013 Oct 5. Aliment Pharmacol Ther. 2013. PMID: 24117503
-
Wheat starch-containing gluten-free flour products in the treatment of coeliac disease and dermatitis herpetiformis. A long-term follow-up study.Scand J Gastroenterol. 1999 Feb;34(2):163-9. doi: 10.1080/00365529950173023. Scand J Gastroenterol. 1999. PMID: 10192194
-
Limitations of xylose tolerance test as a screening procedure in childhood coeliac disease.Arch Dis Child. 1975 Jan;50(1):34-9. doi: 10.1136/adc.50.1.34. Arch Dis Child. 1975. PMID: 1124941 Free PMC article.
-
Monitoring coeliac disease in 2024, time to change practice?Curr Opin Gastroenterol. 2024 May 1;40(3):190-195. doi: 10.1097/MOG.0000000000001009. Epub 2024 Mar 13. Curr Opin Gastroenterol. 2024. PMID: 38547329 Review.
References
-
- Singh P et al. Global Prevalence of Celiac Disease: Systematic Review and Meta-analysis. Clin. Gastroenterol. Hepatol 16, 823–836.e2 (2018). - PubMed
-
- Jansson-Knodell CL et al. Sex Difference in Celiac Disease in Undiagnosed Populations: A Systematic Review and Meta-analysis. Clin. Gastroenterol. Hepatol 17, 1954–1968.e13 (2019). - PubMed
-
- Brown NK, Guandalini S, Semrad C & Kupfer SS A clinician’s guide to celiac disease HLA genetics. Am. J. Gastroenterol 114, 1587–1592 (2019). - PubMed
-
- Tinto N et al. Increased prevalence of celiac disease without gastrointestinal symptoms in adults MICA 5.1 homozygous subjects from the Campania area. Dig. Liver Dis 40, 248–252 (2008). - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials